Aura Biosciences Inc’s recent filing unveils that its Senior Vice President, Finance Elazzouzi Amy unloaded Company’s shares for reported $51737.0 on Aug 18 ’25. In the deal valued at $6.70 per share,7,722 shares were sold. As a result of this transaction, Elazzouzi Amy now holds 86,558 shares worth roughly $0.53 million.
Then, AMY F ELAZZOUZI bought 7,722 shares, generating $51,751 in total proceeds.
Before that, Johnson David Michael bought 20,000 shares. Aura Biosciences Inc shares valued at $98,000 were divested by the Director at a price of $4.90 per share. As a result of the transaction, Johnson David Michael now holds 166,167 shares, worth roughly $1.01 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Scotiabank began covering AURA with “Sector outperform” recommendation on July 27, 2023.
Price Performance Review of AURA
On Friday, Aura Biosciences Inc [NASDAQ:AURA] saw its stock fall -2.88% to $6.08. Over the last five days, the stock has lost -1.62%. Aura Biosciences Inc shares have fallen nearly -36.47% since the year began. Nevertheless, the stocks have fallen -26.03% over the past one year.
How much short interest is there in Aura Biosciences Inc?
A steep rise in short interest was recorded in Aura Biosciences Inc stocks on 2025-08-29, growing by 29975.0 shares to a total of 2.79 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 2.76 million shares. There was a rise of 1.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 19, 2022 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $26 price target.
